In this study:
The Salford Lung Study (SLS) in asthma1 is a pioneering randomised controlled trial (RCT). It is the first study of its kind which measures the effectiveness and safety of a medicine while closely reflecting how typical asthma patients are managed in everyday clinical practice, providing meaningful data for the healthcare community. Having demonstrated the efficacy of the inhaled corticosteroid (ICS) fluticasone furoate and vilanterol in strictly controlled phase III clinical trials, the SLS team aimed to investigate how the medicine performed in everyday clinical practice.
Please login below to download this issue (PDF)